scout
Opinion|Videos|January 23, 2025

HER2 Key Differences and Current Approaches to Biomarker Testing

Panelist discusses how HER2 testing evaluates protein overexpression, gene amplification, and mutations. Although breast and gastric cancers typically show overexpression/amplification, other tumors more commonly harbor mutations.

Episodes in this series

Video content above is prompted by the following:

  • What are the key differences between HER2 overexpression, amplification, and mutations across tumor types? How do these differences affect treatment selection?
  • What is your current approach to biomarker testing for HER2 alterations across different tumor types?

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Subscribe Now!

Related Content